Advertisement

Cost Effectiveness of Smoking Cessation Interventions

  • Christine Godfrey
  • Steve Parrott

Keywords

Smoking Cessation Nicotine Replacement Therapy Tobacco Control Nicotine Patch Smoking Cessation Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.Google Scholar
  2. 2.
    National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2004. http://www.nice.org.uk/pdf/TAP_Methods.pdf (accessed 23 August 2005).Google Scholar
  3. 3.
    Harvard School of Public Health. The Cost Effectiveness Analysis (CEA) Registry, 2005. http://www.hsph.harvard.edu/cearegistry/data/1976-2001_CEratios_comprehensive_4-7-2004. pdf (accessed 24 August 2005).Google Scholar
  4. 4.
    Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004; 328:1519.PubMedCrossRefGoogle Scholar
  5. 5.
    Tengs T, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000; 38:583.PubMedCrossRefGoogle Scholar
  6. 6.
    Orme M, Hogue SL, Kennedy LM, et al. Development of the health and economic consequences of smoking (HE-COS) interactive model. Tob Control 2001; 10:55.PubMedCrossRefGoogle Scholar
  7. 7.
    National Institute for Health and Clinical Excellence (NICE). Lung Cancer: The Diagnosis and Treatment of Lung Cancer. National Cost-impact Report. London: National Institute for Health and Clinical Excellence, 2005. http://www.nice.org.uk/pdf/cg024 fullguideline.pdf (accessed 23 August 2005).Google Scholar
  8. 8.
    Lightwood J, Collins D, Lapsley H, Novotny T. Estimating the costs of tobacco use. In: Jha P, Chaloupka F (eds) Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, 2000.Google Scholar
  9. 9.
    Royal College of Physicians. Going Smoke-free: The Medical Case for Clean Air in the Home, at Work and in Public Places. London: Royal College of Physicians, 2005.Google Scholar
  10. 10.
    Twigg L, Moon G, Walker S. The Smoking Epidemic in England. London: Health Development Agency, 2004.Google Scholar
  11. 11.
    Jha P, Chaloupka F (eds). Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, 2000.Google Scholar
  12. 12.
    Chaloupka F, Hu T-W, Warner K, et al. The taxation of tobacco products. In: Jha P, Chaloupka F (eds) Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, 2000.Google Scholar
  13. 13.
    Lundberg P. Risky Health Behaviour among Adolescents. Lund Economic Studies 100. Lund, Sweden: Department of Economics, Lund University, 2003.Google Scholar
  14. 14.
    Kenkel D, Chen L. Consumer information and tobacco use. In: Jha P, Chaloupka F (eds) Tobacco Control in Developing Countries. Oxford: Oxford Medical Publications, 2000.Google Scholar
  15. 15.
    Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 1998; 53(suppl 5):S1.PubMedGoogle Scholar
  16. 16.
    Mudde A, de Vries H. The reach and effectiveness of a national media-led smoking cessation campaign in the Netherlands. Am J Public Health 1999; 89:346.PubMedGoogle Scholar
  17. 17.
    Secker-Walker R, Worden J, Holland R, Flynn B, Detsky A. A mass media programme to prevent smoking among adolescents: costs and cost effectiveness. Tob Control 1997; 6:207.PubMedCrossRefGoogle Scholar
  18. 18.
    Frieden T, Mostashari F, Kerker B, Miller N, Hajat A, Frankel M. Adult tobacco use levels after intensive tobacco control measures: New York City, 2002–2003. Am J Public Health 2005; 95:1016.PubMedCrossRefGoogle Scholar
  19. 19.
    World Health Organization (WHO-CHOICE). Cost-effectiveness analyses. Web site: http://www3.who.int/whosis/cea (accessed 12 June 2005).Google Scholar
  20. 20.
    Scott Lennox A, Osman L, Reiter E, et al. Cost effectiveness of computer-tailored and non-tailored smoking ces sation letters in general practice: randomised controlled trial. BM 2001; 322:1396.CrossRefGoogle Scholar
  21. 21.
    McAlister A, Rabius V, Geiger A, et al. Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control 2004; 13:85.PubMedCrossRefGoogle Scholar
  22. 22.
    Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997; 278:1759.PubMedCrossRefGoogle Scholar
  23. 23.
    Comas-Fuentes A, Suarez-Gutierrez R, Lopez-Gonzalez M, Cuero Espinar A. Cost-effectiveness of anti-smoking health counseling in primary health care. Gac Sanit 1998; 12:126.PubMedGoogle Scholar
  24. 24.
    West R, McNeill A, Raw M. National smoking cessation guidelines for health professionals: an update. Thorax 2000; 55:989.CrossRefGoogle Scholar
  25. 25.
    Stapleton J, Lowin A, Russell M. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 1999; 354:210.PubMedCrossRefGoogle Scholar
  26. 26.
    Walsey M, McNagny S, Phillips V, Ahluwalia J. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med 1997; 26:264.CrossRefGoogle Scholar
  27. 27.
    Ong M, Glantz S. Free nicotine replacement therapy pro grams vs implementing smoke-free workplaces: a cost-effectiveness comparison. Am J Public Health 2005; 95:969.PubMedCrossRefGoogle Scholar
  28. 28.
    Tauras J, Chaloupka F, Emery S. The impact of advertising on nicotine replacement therapy demand. Soc Sci Med 2005; 60:2351.PubMedGoogle Scholar
  29. 29.
    Alberg A, Margalit R, Burke A, et al. The influence of offering free transdermal nicotine patches on quit rates in a local health department’s smoking cessation program. Addict Behav 2004; 29:1763.PubMedCrossRefGoogle Scholar
  30. 30.
    Halpern M, Khan Z, Young T, et al. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programmes. Am J Health Syst Pharm 2000; 57:1421.PubMedGoogle Scholar
  31. 31.
    Nielson K, Fiore M. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med 2000; 30:209.CrossRefGoogle Scholar
  32. 32.
    Woolacott NF, Jones L, Forbes CA, et al. The clinical effectiveness and cost effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Tech Assess 2002; 6:1.Google Scholar
  33. 33.
    Javitz H, Swan G, Zbikowski S, et al. Cost-effectiveness of different combinations of bupropion SR dose and behavioural treatment for smoking cessation: a societal perspective. Am J Managed Care 2004; 10:217.Google Scholar
  34. 34.
    Gilbert A, Pinget C, Bovet P, et al. The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles. Tob Control 2004; 13:190.PubMedCrossRefGoogle Scholar
  35. 35.
    Warner K. Cost effectiveness of smoking-cessation therapies. Pharmacoeconomics 1997; 11:538.PubMedCrossRefGoogle Scholar
  36. 36.
    Buck D, Richmond R, Mendelsohn C. Cost-effectiveness of a family physician delivered smoking cessation pro gram. Prev Med 2000; 31:641.PubMedCrossRefGoogle Scholar
  37. 37.
    Feenstra T, Hamberg-van Reenen H, Hoogenveen R, Rutten-van Mölken M. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value in Health 2005; 8:178.PubMedCrossRefGoogle Scholar
  38. 38.
    Godfrey C, Parrott S, Coleman T, Pound E. Cost effective ness of English smoking cessation services: evidence from practice. Addict 2005; 100(suppl 2):70.CrossRefGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2006

Authors and Affiliations

  • Christine Godfrey
    • 1
  • Steve Parrott
    • 2
  1. 1.Department of Health Sciences and Centre for Health EconomicsUniversity of YorkYorkUK
  2. 2.Centre for Health EconomicsAlcuin College University of YorkYorkUK

Personalised recommendations